Stemedica
  • About Us
    • Company Overview
    • Board of Directors
    • Management Team
  • Technology
    • Manufacturing
    • Our Progenitor Cells
    • Intellectual Property
  • Clinical
    • Clinical Pipeline
    • Clinical Trial Activities
      • Ischemic Stroke
      • Alzheimer’s Disease
    • R&D
  • Media
    • Press Releases
    • Publications
  • Contact
Select Page

Stemedica Issued US Patent Method for Identifying Neuripotent Cells

by developer imagebeam | Feb 18, 2015 | Intellectual Property

Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced today that the Company has been issued Patent No. US 8,642,286 B2 entitled, Methods for Identifying Neuripotent Cells by the United States Patent...

Stemedica Enters into a Global Distribution Agreement with Life Technologies

by developer imagebeam | Jun 13, 2013 | Partnerships

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and clinical development, announced today they have entered into a Global Distribution Agreement with Life Technologies Corporation. Under the terms of this agreement,...
Next Entries »

Categories

  • Clinical Trials
  • Company Initiatives
  • Intellectual Property
  • Manufacturing
  • Partnerships
  • Publications
  • Subsidiaries

Copyright © 2007-2019 Stemedica Cell Technologies, Inc. All rights reserved.
5375 Mira Sorrento Pl, Suite 100, San Diego CA 92121 +1 858 658 0910